The market is primarily driven by the growing demand for veterinary drugs owing to the rising prevalence of zoonotic diseases, the increasing number of veterinary pharmaceutical players, and the growing animal population, pet ownership, pet humanization & pet expenditure.
The global Veterinary Active Pharmaceutical Ingredients Manufacturing market was valued at US$ 6352 million in 2023 and is anticipated to reach US$ 10580 million by 2030, witnessing a CAGR of 7.5% during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from 拢2.6bn in 2015 to 拢4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about 楼67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 125%.
This report aims to provide a comprehensive presentation of the global market for Veterinary Active Pharmaceutical Ingredients Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Active Pharmaceutical Ingredients Manufacturing.
Report Scope
The Veterinary Active Pharmaceutical Ingredients Manufacturing market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Veterinary Active Pharmaceutical Ingredients Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Active Pharmaceutical Ingredients Manufacturing manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Alivira Animal Health Ltd.
Excel Industries Ltd.
Ofichem Group
Chempro Pharma Private Ltd.
Menadiona
SUANFARMA
Vetpharma (Insud Pharma, S.L.U)
Siflon Drugs
Qilu Pharma
FIS - Fabbrica Italiana Sintetici S.p.A.
Segment by Type
Antiparasitic
Anti-infectives
NSAIDs
Others
Segment by Application
Companion Animals
Production/Food Animals
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Veterinary Active Pharmaceutical Ingredients Manufacturing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Veterinary Active Pharmaceutical Ingredients Manufacturing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Veterinary Active Pharmaceutical Ingredients Manufacturing 麻豆原创 Overview
1.1 Product Overview and Scope of Veterinary Active Pharmaceutical Ingredients Manufacturing
1.2 Veterinary Active Pharmaceutical Ingredients Manufacturing Segment by Type
1.2.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Antiparasitic
1.2.3 Anti-infectives
1.2.4 NSAIDs
1.2.5 Others
1.3 Veterinary Active Pharmaceutical Ingredients Manufacturing Segment by Application
1.3.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing 麻豆原创 Value by Application: (2024-2030)
1.3.2 Companion Animals
1.3.3 Production/Food Animals
1.4 Global Veterinary Active Pharmaceutical Ingredients Manufacturing 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue 2019-2030
1.4.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales 2019-2030
1.4.3 Global Veterinary Active Pharmaceutical Ingredients Manufacturing 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Veterinary Active Pharmaceutical Ingredients Manufacturing 麻豆原创 Competition by Manufacturers
2.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Average Price by Manufacturers (2019-2024)
2.4 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Veterinary Active Pharmaceutical Ingredients Manufacturing, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Veterinary Active Pharmaceutical Ingredients Manufacturing, Product Type & Application
2.7 Veterinary Active Pharmaceutical Ingredients Manufacturing 麻豆原创 Competitive Situation and Trends
2.7.1 Veterinary Active Pharmaceutical Ingredients Manufacturing 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Veterinary Active Pharmaceutical Ingredients Manufacturing Players 麻豆原创 Share by Revenue
2.7.3 Global Veterinary Active Pharmaceutical Ingredients Manufacturing 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Veterinary Active Pharmaceutical Ingredients Manufacturing Retrospective 麻豆原创 Scenario by Region
3.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Region: 2019-2030
3.2.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Region: 2019-2024
3.2.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Region: 2025-2030
3.3 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Region: 2019-2030
3.3.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Region: 2019-2024
3.3.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Region: 2025-2030
3.4 North America Veterinary Active Pharmaceutical Ingredients Manufacturing 麻豆原创 Facts & Figures by Country
3.4.1 North America Veterinary Active Pharmaceutical Ingredients Manufacturing 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Country (2019-2030)
3.4.3 North America Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing 麻豆原创 Facts & Figures by Country
3.5.1 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Country (2019-2030)
3.5.3 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Country (2019-2030)
3.6.3 Asia Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Country (2019-2030)
3.7.3 Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Veterinary Active Pharmaceutical Ingredients Manufacturing 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Veterinary Active Pharmaceutical Ingredients Manufacturing 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Country (2019-2030)
3.8.3 Middle East and Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Type (2019-2030)
4.1.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Type (2019-2024)
4.1.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Type (2025-2030)
4.1.3 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Type (2019-2030)
4.2.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Type (2019-2024)
4.2.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Type (2025-2030)
4.2.3 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Price by Type (2019-2030)
5 Segment by Application
5.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Application (2019-2030)
5.1.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Application (2019-2024)
5.1.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Application (2025-2030)
5.1.3 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Application (2019-2030)
5.2.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Application (2019-2024)
5.2.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Application (2025-2030)
5.2.3 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Alivira Animal Health Ltd.
6.1.1 Alivira Animal Health Ltd. Corporation Information
6.1.2 Alivira Animal Health Ltd. Description and Business Overview
6.1.3 Alivira Animal Health Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Alivira Animal Health Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Product Portfolio
6.1.5 Alivira Animal Health Ltd. Recent Developments/Updates
6.2 Excel Industries Ltd.
6.2.1 Excel Industries Ltd. Corporation Information
6.2.2 Excel Industries Ltd. Description and Business Overview
6.2.3 Excel Industries Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Excel Industries Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Product Portfolio
6.2.5 Excel Industries Ltd. Recent Developments/Updates
6.3 Ofichem Group
6.3.1 Ofichem Group Corporation Information
6.3.2 Ofichem Group Description and Business Overview
6.3.3 Ofichem Group Veterinary Active Pharmaceutical Ingredients Manufacturing Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Ofichem Group Veterinary Active Pharmaceutical Ingredients Manufacturing Product Portfolio
6.3.5 Ofichem Group Recent Developments/Updates
6.4 Chempro Pharma Private Ltd.
6.4.1 Chempro Pharma Private Ltd. Corporation Information
6.4.2 Chempro Pharma Private Ltd. Description and Business Overview
6.4.3 Chempro Pharma Private Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Chempro Pharma Private Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Product Portfolio
6.4.5 Chempro Pharma Private Ltd. Recent Developments/Updates
6.5 Menadiona
6.5.1 Menadiona Corporation Information
6.5.2 Menadiona Description and Business Overview
6.5.3 Menadiona Veterinary Active Pharmaceutical Ingredients Manufacturing Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Menadiona Veterinary Active Pharmaceutical Ingredients Manufacturing Product Portfolio
6.5.5 Menadiona Recent Developments/Updates
6.6 SUANFARMA
6.6.1 SUANFARMA Corporation Information
6.6.2 SUANFARMA Description and Business Overview
6.6.3 SUANFARMA Veterinary Active Pharmaceutical Ingredients Manufacturing Sales, Revenue and Gross Margin (2019-2024)
6.6.4 SUANFARMA Veterinary Active Pharmaceutical Ingredients Manufacturing Product Portfolio
6.6.5 SUANFARMA Recent Developments/Updates
6.7 Vetpharma (Insud Pharma, S.L.U)
6.6.1 Vetpharma (Insud Pharma, S.L.U) Corporation Information
6.6.2 Vetpharma (Insud Pharma, S.L.U) Description and Business Overview
6.6.3 Vetpharma (Insud Pharma, S.L.U) Veterinary Active Pharmaceutical Ingredients Manufacturing Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Vetpharma (Insud Pharma, S.L.U) Veterinary Active Pharmaceutical Ingredients Manufacturing Product Portfolio
6.7.5 Vetpharma (Insud Pharma, S.L.U) Recent Developments/Updates
6.8 Siflon Drugs
6.8.1 Siflon Drugs Corporation Information
6.8.2 Siflon Drugs Description and Business Overview
6.8.3 Siflon Drugs Veterinary Active Pharmaceutical Ingredients Manufacturing Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Siflon Drugs Veterinary Active Pharmaceutical Ingredients Manufacturing Product Portfolio
6.8.5 Siflon Drugs Recent Developments/Updates
6.9 Qilu Pharma
6.9.1 Qilu Pharma Corporation Information
6.9.2 Qilu Pharma Description and Business Overview
6.9.3 Qilu Pharma Veterinary Active Pharmaceutical Ingredients Manufacturing Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Qilu Pharma Veterinary Active Pharmaceutical Ingredients Manufacturing Product Portfolio
6.9.5 Qilu Pharma Recent Developments/Updates
6.10 FIS - Fabbrica Italiana Sintetici S.p.A.
6.10.1 FIS - Fabbrica Italiana Sintetici S.p.A. Corporation Information
6.10.2 FIS - Fabbrica Italiana Sintetici S.p.A. Description and Business Overview
6.10.3 FIS - Fabbrica Italiana Sintetici S.p.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales, Revenue and Gross Margin (2019-2024)
6.10.4 FIS - Fabbrica Italiana Sintetici S.p.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Product Portfolio
6.10.5 FIS - Fabbrica Italiana Sintetici S.p.A. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Veterinary Active Pharmaceutical Ingredients Manufacturing Industry Chain Analysis
7.2 Veterinary Active Pharmaceutical Ingredients Manufacturing Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Veterinary Active Pharmaceutical Ingredients Manufacturing Production Mode & Process
7.4 Veterinary Active Pharmaceutical Ingredients Manufacturing Sales and 麻豆原创ing
7.4.1 Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Channels
7.4.2 Veterinary Active Pharmaceutical Ingredients Manufacturing Distributors
7.5 Veterinary Active Pharmaceutical Ingredients Manufacturing Customers
8 Veterinary Active Pharmaceutical Ingredients Manufacturing 麻豆原创 Dynamics
8.1 Veterinary Active Pharmaceutical Ingredients Manufacturing Industry Trends
8.2 Veterinary Active Pharmaceutical Ingredients Manufacturing 麻豆原创 Drivers
8.3 Veterinary Active Pharmaceutical Ingredients Manufacturing 麻豆原创 Challenges
8.4 Veterinary Active Pharmaceutical Ingredients Manufacturing 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Alivira Animal Health Ltd.
Excel Industries Ltd.
Ofichem Group
Chempro Pharma Private Ltd.
Menadiona
SUANFARMA
Vetpharma (Insud Pharma, S.L.U)
Siflon Drugs
Qilu Pharma
FIS - Fabbrica Italiana Sintetici S.p.A.
听
听
*If Applicable.